Chronic Spinal Cord Injury: Clinical Trials

13 trials for Chronic Spinal Cord Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 recruiting, 1 enrolling by invitation, 1 unknown. 8 Not applicable, 4 Phase 1, 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 4, Recruiting 2, Enrolling by invitation 1, Unknown 1
Phase 14Completed 3, Recruiting 1
Phase 24Completed 3, Recruiting 1
Phase 31Recruiting 1

Follow Chronic Spinal Cord Injury: new trials by email Literature Review of Chronic Spinal Cord Injury trials Research Report on Chronic Spinal Cord Injury

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
NVG-291, Placebo - Chronic Spinal Cord Injury
Phase 3RecruitingNervGen Pharma1502026-09-282026-11-06
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
ARC-IM Therapy - Spinal Cord Injury, SCI
Not applicableRecruitingEcole Polytechnique Fédérale de Lausanne122026-04-012026-04-21
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
STUP-001 - Spinal Cord Injury, Chronic Spinal Cord Injury
Phase 1 / Phase 2RecruitingYonsei University92025-07-302025-07-16
Abdominal Electrical Stimulation for Bowel Dysfunction in SCI
Abdominal transcutaneous electrical stimulation (TES) - Chronic Spinal Cord Injury
Not applicableEnrolling by invitationUniversity of Alberta122025-07-142026-06-25
NVG-291 in Spinal Cord Injury Subjects
NVG-291, Placebo Injection - Spinal Cord Injuries, Chronic Spinal Cord Injury
Phase 1 / Phase 2CompletedNervGen Pharma242023-08-082026-11-20
RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
RESToration Of Rehabilitative function with Epidural spinal Stimulation - Chronic Spinal Cord Injury
Not applicableRecruitingNational Neuroscience Institute182022-12-192026-01-26
LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury
LIFT System - Chronic Spinal Cord Injury
Not applicableCompletedONWARD Medical, Inc.172022-03-032022-09-16
The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury
LIFT System - Chronic Spinal Cord Injury
Not applicableCompletedONWARD Medical, Inc.652021-01-082022-09-16
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
High Dose, Low dose - Chronic Spinal Cord Injury, Neurogenic Bladder
Not applicableCompletedThe University of Texas Health Science Center, Houston502019-11-192024-10-15
AXER-204 in Participants With Chronic Spinal Cord Injury
AXER-204, Placebo - Chronic Spinal Cord Injury
Phase 1 / Phase 2CompletedReNetX Bio, Inc.522019-07-162023-08-22
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation
4-week TTNS home-based protocol - Chronic Spinal Cord Injury, Neurogenic Bowel
Not applicableCompletedThe University of Texas Health Science Center, Houston162018-03-132021-10-29
Impact of Persistent Conductances on Motor Unit Firing in SCI
sugar pill, Riluzole, Isradipine - Chronic Spinal Cord Injury
Not applicableUnknownShirley Ryan AbilityLab502009-06-012014-05-13
Cell Transplant in Spinal Cord Injury Patients
Autologous bone marrow transplant, Physical therapy - Chronic Spinal Cord Injury
Phase 1 / Phase 2CompletedCairo University802005-05-012009-01-05

Narrower conditions

Spinal Cord Injuries (7)  ·  Quadriplegia (3)  ·  Intestinal Diseases (1)  ·  Neurogenic Bowel (1)  ·  Urinary Bladder, Neurogenic (1)

Broader conditions

Nervous System Diseases (11)  ·  Central Nervous System Diseases (7)  ·  Spinal Cord Diseases (7)  ·  Trauma, Nervous System (7)  ·  Wounds and Injuries (7)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Paralysis (3)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Isradipine (1)  ·  Memantine (1)  ·  Physical Therapy Modalities (1)  ·  Riluzole (1)  ·  Sugars (1)

Sponsors

NervGen Pharma (2)  ·  ONWARD Medical, Inc. (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  Cairo University (1)  ·  Ecole Polytechnique Fédérale de Lausanne (1)  ·  National Neuroscience Institute (1)  ·  ReNetX Bio, Inc. (1)  ·  Shirley Ryan AbilityLab (1)  ·  University of Alberta (1)  ·  Yonsei University (1)

Countries

United States (7)  ·  Canada (3)  ·  Egypt (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Argyos Stampas, MD (1)  ·  Argyrios Stampas, MD (1)  ·  Candace Tefertiller, PT, DPT, PhD, NCS (1)  ·  Chester Ho, MD (1)  ·  Chet Moritz, PhD (1)  ·  Edelle Field-Fote, PT, PhD (1)  ·  George Maynard, PhD (1)  ·  Jocelyne Bloch, Prof. Dr. MD (1)  ·  Randall Kaye, M.D. (1)

Results publications

PMID 23452836, PMID 37479373, PMID 38769431, PMID 39093916, PMID 40568376, PMID 40744729, PMID 41019097

NIH funding

KL2TR003168 (1)